BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2162 results:

  • 1. P4HA2 contributes to head and neck squamous cell carcinoma progression and emt through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.
    Coperchini F; Greco A; Croce L; Teliti M; Calì B; Chytiris S; Magri F; Rotondi M
    Environ Int; 2024 May; 187():108717. PubMed ID: 38728818
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
    Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
    Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
    Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
    PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CLIP170 inhibits the metastasis and emt of papillary thyroid cancer through the TGF-β pathway.
    Ma B; Xu Y; Gao H; Yang Y; Pan Y; You C
    Med Oncol; 2024 May; 41(6):137. PubMed ID: 38705933
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy.
    Mi L; Liu J; Zhang Y; Su A; Tang M; Xing Z; He T; Wei T; Li Z; Wu W
    Phytomedicine; 2024 Jul; 129():155670. PubMed ID: 38704915
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
    Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
    J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PLAU promotes cell proliferation and migration of head and neck cancer via STAT3 signaling pathway.
    Cui X; Sun H; Liu X; Bai Y; Bai Y; Cui Y; Wang B; Zhang S; Li X
    Exp Cell Res; 2024 May; 438(2):114056. PubMed ID: 38663475
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway.
    Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
    Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
    Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
    Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
    Xu M; Fan Y; Zou G; Yang Q; Xu F
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Biomarker Potential of
    Ju Y; Zhu F; Fang B
    Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis.
    Li Y; Zhou Y; Zhao C; Liu L; He Q; Shang K; Xu X; Luo X; Zhou D; Jin F
    Oral Oncol; 2024 May; 152():106798. PubMed ID: 38615583
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
    Cheng Y; Song Z; Fang X; Tang Z
    Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth.
    Song XQ; Chen BB; Jin YM; Wang CY
    Cell Cycle; 2024 Feb; 23(3):262-278. PubMed ID: 38597826
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma.
    Cai L; Zhu H; Mou Q; Wong PY; Lan L; Ng CWK; Lei P; Cheung MK; Wang D; Wong EWY; Lau EHL; Yeung ZWC; Lai R; Meehan K; Fung S; Chan KCA; Lui VWY; Cheng ASL; Yu J; Chan PKS; Chan JYK; Chen Z
    NPJ Biofilms Microbiomes; 2024 Apr; 10(1):39. PubMed ID: 38589501
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Downregulation of SETDB1 suppresses epithelial mesenchymal transition and invasion and metastasis in oral cancer via SOX7 methylation].
    Hao Y; Bai XY; Huo F; Chen XB
    Shanghai Kou Qiang Yi Xue; 2024 Feb; 33(1):30-35. PubMed ID: 38583021
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 109.